SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from AMACORE GROUP, INC. (CIK 0000949394) — Nov 8, 2005

AMACORE GROUP, INC. (CIK 0000949394)
Date: Nov. 8, 2005 · CIK: 0000949394 · Accession: 0001167966-05-001565

AI Filing Summary & Sentiment

File numbers found in text: 333-121308

Referenced dates: January 13, 2005

Date
November 4, 2005
Author
/s/
Form
CORRESP
Company
AMACORE GROUP, INC. (CIK 0000949394)

Letter

Securities and Exchange Commission (formerly Eye Care International, Inc.) Registration Statement on Form SB-2/A Filed November 4, 2005 Registration No. 333-121308

Re:

Dear Mr. Tiernan:

In response to your November 8, 2005 email to me, we respectfully request acceleration of the effective date of the above-referenced registration statement to 1 p.m. on Wednesday, November 9, 2005, or as soon thereafter as possible.

In the comment letter dated January 13, 2005 and July 27, 2005, Elaine Wolff, Branch Chief, called our attention to Rules 460 and 461 of the Securities Act of 1933 concerning requesting acceleration of the effective date of the registration statement. With respect to Rule 460, the registrant has made no distribution of the preliminary prospectus. However, the registrant shall provide copies of the prospectus included as part of the effective registration statement to all selling security holders together with a letter bringing to their attention certain matter of importance concerning certain statutory provisions of the SEC and its rules and regulations applicable to all selling security holders, to assist them in understanding their responsibilities under the federal securities laws and Regulation M in connection with their offer and sale of their shares, including: the requirement to deliver a prospectus; the need to notify us when their offer and sale of shares is complete; the prohibition of bidding for or buying any shares in the market, directly or indirectly, until the offer and sale of shares of all selling security holders is complete; and the prohibition of making any representations or giving any information about the registrant or its securities that is not contained in the prospectus. With respect to Rule 461, in requesting acceleration, the registrant is aware of its obligations under the Securities Act of 1933 and those of the selling security holders to comply with Regulation M.

The registrant acknowledges:

(1)

that should the Commission or Staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing,

(2)

that the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing, and

(3)

that the registrant may not assert this action as defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Thank you for your attention.

Sincerely,
/s/
James
L. Koenig

Show Raw Text
CORRESP
1
filename1.htm

      Request for Aceleration

    November
      8, 2005

    By
      Facsimile: (202) 772-9209

    Mr.
      Michael McTiernan, Special Counsel

    Securities
      and Exchange Commission

    100F
      Street, NE

    Washington,
      D.C. 20549

            Re:

              The
                Amacore Group, Inc.

              (formerly
                Eye Care International, Inc.)

              Registration
                Statement on Form SB-2/A

              Filed
                November 4, 2005

              Registration
                No. 333-121308

    Dear
      Mr.
      Tiernan:

    In
      response to your November 8, 2005 email to me, we respectfully request
      acceleration of the effective date of the above-referenced registration
      statement to 1 p.m. on Wednesday, November 9, 2005, or as soon thereafter as
      possible.

    In
      the
      comment letter dated January 13, 2005 and July 27, 2005, Elaine Wolff, Branch
      Chief, called our attention to Rules 460 and 461 of the Securities Act of 1933
      concerning requesting acceleration of the effective date of the registration
      statement. With respect to Rule 460, the registrant has made no distribution
      of
      the preliminary prospectus. However, the registrant shall provide copies of
      the
      prospectus included as part of the effective registration statement to all
      selling security holders together with a letter bringing to their attention
      certain matter of importance concerning certain statutory provisions of the
      SEC
      and its rules and regulations applicable to all selling security holders, to
      assist them in understanding their responsibilities under the federal securities
      laws and Regulation M in connection with their offer and sale of their shares,
      including: the requirement to deliver a prospectus; the need to notify us when
      their offer and sale of shares is complete; the prohibition of bidding for
      or
      buying any shares in the market, directly or indirectly, until the offer and
      sale of shares of all selling security holders is complete; and the prohibition
      of making any representations or giving any information about the registrant
      or
      its securities that is not contained in the prospectus. With respect to Rule
      461, in requesting acceleration, the registrant is aware of its obligations
      under the Securities
      Act of 1933 and those of the selling security holders to comply with Regulation
      M.

    The
      registrant acknowledges:

              (1)

              that
                should the Commission or Staff, acting pursuant to delegated authority,
                declare the filing effective, it does not foreclose the Commission
                from
                taking any action with respect to the
                filing,

              (2)

              that
                the action of the Commission or the Staff, acting pursuant to delegated
                authority, in declaring the filing effective, does not relieve the
                registrant from its full responsibility for the adequacy and accuracy
                of
                the disclosure in the filing, and

              (3)

              that
                the registrant may not assert this action as defense in any proceeding
                initiated by the Commission or any person under the federal securities
                laws of the United States.

    Thank
      you
      for your attention.

    Sincerely,

    /s/
      James
      L. Koenig

    James
      L.
      Koenig

    Acting
      Chief Financial Officer

    cc:
      David
      J. Levenson